Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
96M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
24.6M
-
Shares change
-
+4.66M
-
Total reported value, excl. options
-
$203M
-
Value change
-
+$37.7M
-
Put/Call ratio
-
0.21
-
Number of buys
-
41
-
Number of sells
-
-25
-
Price
-
$8.27
Significant Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) as of Q1 2023
84 filings reported holding CABA - Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share as of Q1 2023.
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.6M shares
of 96M outstanding shares and own 25.57% of the company stock.
Largest 10 shareholders include FRED ALGER MANAGEMENT, LLC (4.02M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.54M shares), Lynx1 Capital Management LP (2.45M shares), VR Adviser, LLC (1.97M shares), COMMODORE CAPITAL LP (1.84M shares), Cormorant Asset Management, LP (1.82M shares), BAKER BROS. ADVISORS LP (1.34M shares), VANGUARD GROUP INC (1.11M shares), JENNISON ASSOCIATES LLC (781K shares), and PERCEPTIVE ADVISORS LLC (725K shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.